CROI 2024 New Investigator Luminary Session
Select one Luminary Session. Please note: Session attendance is limited and will be on a first-come, first-served basis. (more…)
The Conference on Retroviruses and Opportunistic Infections (CROI)
The 31st Conference on Retroviruses and Opportunistic Infections will be March 3 through 6, 2024, in Denver, Colorado, USA. As always, the best and most consequential original research will define the science at CROI, including research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. Research that has not been published or (more…)
The Scott M. Hammer Annual Update on HIV Management in New York, New York
Last Modified: Program Description Join us for (more…)
Latest Update on Urgent Virus Outbreaks: March 2024
Program Description IAS–USA Dialogues (formerly COVID-19 Dialogues) were created to address an urgent need for reliable scientific information, with understanding of SARS-CoV-2 and COVID-19 disease changing almost daily. In response, the IAS−USA created a program that brought together leading experts to discuss the latest data and research regarding COVID-19. Although the Dialogues continue to (more…)
New Drugs on the Horizon for HIV Treatment: 2024 and Beyond!
Overview Assessment of Needs Innovative medications for the treatment of people with HIV-1 continue to undergo rigorous research and development. This webinar will discuss current data around the latest pharmacologic treatments for HIV, including new data presented at the 31st Conference on Retroviruses and Opportunistic Infections, and new investigational agents in the development pipeline. (more…)
Antiretroviral Management of HIV: New Data From the 2024 Conference on Retroviruses and Opportunistic Infections (CROI)
Overview Assessment of Needs This webinar will discuss current data around antiretroviral management of HIV, including new data presented at the 31st Conference on Retroviruses and Opportunistic Infections. Learning Objectives On completion of this activity, learners will be able to: List the most recent findings from clinical studies in antiretroviral management of HIV and (more…)
